Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex

Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex

<p>Supplemental Figures 1-4</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Michael D. Nyquist (16918265) (author)
Diğer Yazarlar:	Ilsa M. Coleman (15124374) (author), Jared M. Lucas (15124383) (author), Dapei Li (16918268) (author), Brian Hanratty (14950515) (author), Hannah Meade (16918271) (author), Elahe A. Mostaghel (16918274) (author), Stephen R. Plymate (16918277) (author), Eva Corey (14845888) (author), Michael C. Haffner (14960871) (author), Peter S. Nelson (15044327) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Tumor Biology Therapeutic Research and Development Drug Mechanisms Cell cycle mechanisms of anticancer drug action Endocrinology Hormone signaling and inhibitors Genitourinary Cancers Prostate cancer
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
Yazar:: Michael D. Nyquist (16918265)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
Yazar:: Juliana Navarro-Yepes (17079059)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
Yazar:: Lixuan Wei (14962431)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S9 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
Yazar:: Jesse C. Patterson (14962862)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
Yazar:: Nicole A. Traphagen (16677391)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
Yazar:: Nicole A. Traphagen (16677391)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S1 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
Yazar:: Fang Wei (15057172)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S2 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
Yazar:: Fang Wei (15057172)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S3 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
Yazar:: Fang Wei (15057172)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S4 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
Yazar:: Fang Wei (15057172)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S5 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
Yazar:: Fang Wei (15057172)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S6 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
Yazar:: Fang Wei (15057172)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S7 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
Yazar:: Fang Wei (15057172)
Baskı/Yayın Bilgisi: (2025)

Supplementary Movie S8 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
Yazar:: Fang Wei (15057172)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Yazar:: Evangeline R. Jackson (15558808)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
Yazar:: Gwo Yaw Ho (14961416)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
Yazar:: Xiaomin Zhang (14963822)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 2 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
Yazar:: Xiaomin Zhang (14963822)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 3 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
Yazar:: Xiaomin Zhang (14963822)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 4 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
Yazar:: Xiaomin Zhang (14963822)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 5 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity
Yazar:: Xiaomin Zhang (14963822)
Baskı/Yayın Bilgisi: (2025)

Data.xlsx
Yazar:: Atakan CORTU (21635582)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women
Yazar:: Ching-Hung Lin (15110557)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_Population pharmacokinetics/pharmacodynamics and safety of YPEG-rhGH in elderly subjects.docx
Yazar:: Yajie He (20323682)
Baskı/Yayın Bilgisi: (2025)

<b>Patient and Physician Perspectives on Prostate Cancer Data Presented at ASCO 2025: A Podcast</b>
Yazar:: Adis Journals on behalf of: (10953492)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S1 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S10 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S11 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S12 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S13 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S14 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S2 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_i5o2ovflm7kfdnq8juq80f6fvk